168 related articles for article (PubMed ID: 34975913)
1. Celiac Disease After Administration of Immune Checkpoint Inhibitors: A Case Report.
Leblanc J; Hoibian S; Boucraut A; Ratone JP; Stoffaes L; Dano D; Louvel-Perrot D; Chanez B; Chretien AS; Madroszyk A; Rochigneux P
Front Immunol; 2021; 12():799666. PubMed ID: 34975913
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitor-associated celiac disease.
Badran YR; Shih A; Leet D; Mooradian MJ; Coromilas A; Chen J; Kem M; Zheng H; Borowsky J; Misdraji J; Mino-Kenudson M; Dougan M
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581063
[TBL] [Abstract][Full Text] [Related]
3. A case of checkpoint inhibitor-induced celiac disease.
Alsaadi D; Shah NJ; Charabaty A; Atkins MB
J Immunother Cancer; 2019 Aug; 7(1):203. PubMed ID: 31383006
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy.
Falade AS; Reynolds KL; Zubiri L; Deshpande V; Fintelmann FJ; Dougan M; Mooradian MJ
Front Immunol; 2022; 13():871452. PubMed ID: 35493494
[TBL] [Abstract][Full Text] [Related]
5. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
6. Celiac Disease in Children.
Jimenez J; Loveridge-Lenza B; Horvath K
Pediatr Clin North Am; 2021 Dec; 68(6):1205-1219. PubMed ID: 34736585
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges.
Parikh K; Hendriks LEL; Bironzo P; Remon J
Cancer Treat Rev; 2021 Sep; 99():102250. PubMed ID: 34174669
[TBL] [Abstract][Full Text] [Related]
8. High levels of immunoglobulin A anti-tissue transglutaminase antibodies at diagnosis are a predictive factor for celiac hepatitis.
Albuquerque A; Rodrigues S; Macedo G
Scand J Gastroenterol; 2016 Nov; 51(11):1316-20. PubMed ID: 27387923
[TBL] [Abstract][Full Text] [Related]
9. Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial.
Disselhorst MJ; Quispel-Janssen J; Lalezari F; Monkhorst K; de Vries JF; van der Noort V; Harms E; Burgers S; Baas P
Lancet Respir Med; 2019 Mar; 7(3):260-270. PubMed ID: 30660511
[TBL] [Abstract][Full Text] [Related]
10. Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy.
Nurmi R; Korponay-Szabó I; Laurila K; Huhtala H; Niemelä O; Mustonen J; Mäkelä S; Kaukinen K; Lindfors K
Nutrients; 2021 May; 13(5):. PubMed ID: 34064541
[TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma.
Cui W; Popat S
Drugs; 2021 Jun; 81(9):971-984. PubMed ID: 34106454
[TBL] [Abstract][Full Text] [Related]
12. A Caucasian American patient with celiac disease diagnosed in Japan and successfully treated with a gluten-free diet.
Wada H; Hayashida M; Sato T; Minowa S; Ikezaki O; Mitsui T; Miura M; Ohmori Y; Saito D; Sakuraba A; Kamiichi H; Tokunaga K; Mochizuki M; Shibahara J; Mori H; Hisamatsu T
Clin J Gastroenterol; 2018 Feb; 11(1):23-28. PubMed ID: 29094324
[TBL] [Abstract][Full Text] [Related]
13. Reversible primary adrenal insufficiency related to anti-programmed cell-death 1 protein active immunotherapy: Insight into an unforeseen outcome of a rare immune-related adverse event.
Deligiorgi MV; Trafalis DT
Int Immunopharmacol; 2020 Dec; 89(Pt B):107050. PubMed ID: 33069924
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to tissue transglutaminase as predictors of celiac disease.
Dieterich W; Laag E; Schöpper H; Volta U; Ferguson A; Gillett H; Riecken EO; Schuppan D
Gastroenterology; 1998 Dec; 115(6):1317-21. PubMed ID: 9834256
[TBL] [Abstract][Full Text] [Related]
15. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
16. Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?
Giorgio F; Principi M; Losurdo G; Piscitelli D; Iannone A; Barone M; Amoruso A; Ierardi E; Di Leo A
Nutrients; 2015 Sep; 7(9):7486-504. PubMed ID: 26371035
[TBL] [Abstract][Full Text] [Related]
17. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.
Leonard MM; Weir DC; DeGroote M; Mitchell PD; Singh P; Silvester JA; Leichtner AM; Fasano A
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):286-291. PubMed ID: 28112686
[TBL] [Abstract][Full Text] [Related]
18. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease.
Conti V; Leone MC; Casato M; Nicoli M; Granata G; Carlesimo M
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):54-7. PubMed ID: 25781195
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.
Rose C; Armbruster FP; Ruppert J; Igl BW; Zillikens D; Shimanovich I
J Am Acad Dermatol; 2009 Jul; 61(1):39-43. PubMed ID: 19344979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
